CHRS Annual D&A
$3.79 M
+$92.00 K+2.49%
31 December 2023
Summary:
As of January 23, 2025, CHRS annual depreciation & amortization is $3.79 million, with the most recent change of +$92.00 thousand (+2.49%) on December 31, 2023. During the last 3 years, it has risen by +$903.00 thousand (+31.27%). CHRS annual D&A is now at all-time high.CHRS Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CHRS Quarterly D&A
$1.55 M
+$362.00 K+30.50%
30 September 2024
Summary:
As of January 23, 2025, CHRS quarterly depreciation & amortization is $1.55 million, with the most recent change of +$362.00 thousand (+30.50%) on September 30, 2024. Over the past year, it has increased by +$650.00 thousand (+72.30%). CHRS quarterly D&A is now at all-time high.CHRS Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CHRS TTM D&A
$5.31 M
+$650.00 K+13.96%
30 September 2024
Summary:
As of January 23, 2025, CHRS TTM depreciation & amortization is $5.31 million, with the most recent change of +$650.00 thousand (+13.96%) on September 30, 2024. Over the past year, it has increased by +$1.53 million (+40.44%). CHRS TTM D&A is now at all-time high.CHRS TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CHRS Depreciation And Amortization Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +2.5% | +72.3% | +40.4% |
| 3 y3 years | +31.3% | +76.0% | +37.0% |
| 5 y5 years | +17.2% | +76.0% | +37.0% |
CHRS Depreciation And Amortization High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +9.8% | at high | +102.0% | at high | +57.4% |
| 5 y | 5-year | at high | +31.3% | at high | +155.2% | at high | +83.7% |
| alltime | all time | at high | +1615.4% | at high | +1235.3% | at high | +4474.1% |
Coherus BioSciences Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $1.55 M(+30.5%) | $5.31 M(+14.0%) |
| June 2024 | - | $1.19 M(-21.2%) | $4.66 M(+7.1%) |
| Mar 2024 | - | $1.51 M(+41.8%) | $4.35 M(+14.7%) |
| Dec 2023 | $3.79 M(+2.5%) | $1.06 M(+18.2%) | $3.79 M(+0.3%) |
| Sept 2023 | - | $899.00 K(+2.2%) | $3.78 M(-2.5%) |
| June 2023 | - | $880.00 K(-7.3%) | $3.87 M(-0.2%) |
| Mar 2023 | - | $949.00 K(-9.6%) | $3.88 M(+4.9%) |
| Dec 2022 | $3.70 M(+7.1%) | $1.05 M(+5.5%) | $3.70 M(+6.1%) |
| Sept 2022 | - | $995.00 K(+12.2%) | $3.48 M(+3.0%) |
| June 2022 | - | $887.00 K(+15.6%) | $3.38 M(+0.3%) |
| Mar 2022 | - | $767.00 K(-8.3%) | $3.37 M(-2.4%) |
| Dec 2021 | $3.45 M(+19.6%) | $836.00 K(-6.3%) | $3.45 M(-0.1%) |
| Sept 2021 | - | $892.00 K(+1.7%) | $3.46 M(+6.1%) |
| June 2021 | - | $877.00 K(+3.3%) | $3.26 M(+4.1%) |
| Mar 2021 | - | $849.00 K(+1.1%) | $3.13 M(+8.4%) |
| Dec 2020 | $2.89 M(-11.4%) | $840.00 K(+21.2%) | $2.89 M(-6.9%) |
| Sept 2020 | - | $693.00 K(-7.4%) | $3.10 M(-4.5%) |
| June 2020 | - | $748.00 K(+23.2%) | $3.25 M(+2.3%) |
| Mar 2020 | - | $607.00 K(-42.5%) | $3.17 M(-2.6%) |
| Dec 2019 | $3.26 M | $1.05 M(+25.7%) | $3.26 M(+15.7%) |
| Sept 2019 | - | $839.00 K(+24.5%) | $2.82 M(+1.5%) |
| June 2019 | - | $674.00 K(-2.5%) | $2.78 M(-7.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | $691.00 K(+12.7%) | $3.00 M(-7.1%) |
| Dec 2018 | $3.23 M(-4.8%) | $613.00 K(-23.2%) | $3.23 M(-8.8%) |
| Sept 2018 | - | $798.00 K(-11.5%) | $3.55 M(+0.8%) |
| June 2018 | - | $902.00 K(-2.2%) | $3.52 M(+1.9%) |
| Mar 2018 | - | $922.00 K(-0.4%) | $3.46 M(+1.7%) |
| Dec 2017 | $3.40 M(+13.4%) | $926.00 K(+20.3%) | $3.40 M(+3.9%) |
| Sept 2017 | - | $770.00 K(-8.0%) | $3.27 M(+0.5%) |
| June 2017 | - | $837.00 K(-3.2%) | $3.25 M(+3.4%) |
| Mar 2017 | - | $865.00 K(+8.5%) | $3.14 M(+4.9%) |
| Dec 2016 | $3.00 M(+60.3%) | $797.00 K(+5.8%) | $3.00 M(+7.0%) |
| Sept 2016 | - | $753.00 K(+3.3%) | $2.80 M(+4.4%) |
| June 2016 | - | $729.00 K(+1.7%) | $2.68 M(+14.0%) |
| Mar 2016 | - | $717.00 K(+19.3%) | $2.35 M(+25.9%) |
| Dec 2015 | $1.87 M(+177.3%) | $601.00 K(-5.5%) | $1.87 M(+24.4%) |
| Sept 2015 | - | $636.00 K(+59.0%) | $1.50 M(+41.9%) |
| June 2015 | - | $400.00 K(+72.4%) | $1.06 M(+34.1%) |
| Mar 2015 | - | $232.00 K(-1.3%) | $790.00 K(+17.2%) |
| Dec 2014 | $674.00 K(+66.8%) | $235.00 K(+22.4%) | $674.00 K(+53.5%) |
| Sept 2014 | - | $192.00 K(+46.6%) | $439.00 K(+77.7%) |
| June 2014 | - | $131.00 K(+12.9%) | $247.00 K(+112.9%) |
| Mar 2014 | - | $116.00 K | $116.00 K |
| Dec 2013 | $404.00 K(+82.8%) | - | - |
| Dec 2012 | $221.00 K | - | - |
FAQ
- What is Coherus BioSciences annual depreciation & amortization?
- What is the all time high annual D&A for Coherus BioSciences?
- What is Coherus BioSciences annual D&A year-on-year change?
- What is Coherus BioSciences quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Coherus BioSciences?
- What is Coherus BioSciences quarterly D&A year-on-year change?
- What is Coherus BioSciences TTM depreciation & amortization?
- What is the all time high TTM D&A for Coherus BioSciences?
- What is Coherus BioSciences TTM D&A year-on-year change?
What is Coherus BioSciences annual depreciation & amortization?
The current annual D&A of CHRS is $3.79 M
What is the all time high annual D&A for Coherus BioSciences?
Coherus BioSciences all-time high annual depreciation & amortization is $3.79 M
What is Coherus BioSciences annual D&A year-on-year change?
Over the past year, CHRS annual depreciation & amortization has changed by +$92.00 K (+2.49%)
What is Coherus BioSciences quarterly depreciation & amortization?
The current quarterly D&A of CHRS is $1.55 M
What is the all time high quarterly D&A for Coherus BioSciences?
Coherus BioSciences all-time high quarterly depreciation & amortization is $1.55 M
What is Coherus BioSciences quarterly D&A year-on-year change?
Over the past year, CHRS quarterly depreciation & amortization has changed by +$650.00 K (+72.30%)
What is Coherus BioSciences TTM depreciation & amortization?
The current TTM D&A of CHRS is $5.31 M
What is the all time high TTM D&A for Coherus BioSciences?
Coherus BioSciences all-time high TTM depreciation & amortization is $5.31 M
What is Coherus BioSciences TTM D&A year-on-year change?
Over the past year, CHRS TTM depreciation & amortization has changed by +$1.53 M (+40.44%)